Two pi’s, two indications. Two different dosing guidelines. One manufacturer. Eagle Pharmaceuticals. All of the oncology pharmacist boards they are the same. Surprising that the two are the same exact product. and now this https://www.agg.com/news-insights/publications/orphan-drug-company-refuses-to-take-it-easy-and-prevails-in-court-case-against-fda-relating-to-orphan-drug-exclusivity/
